Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion type Assertion NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_head.
- NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion description "[Up-regulated genes in post-CT tumors included substantial number of genes with previously known implication in mechanisms of chemoresistance (TOP2A, ETV4, ABCF2, PRDX2, COX2, COX7B, MUC1, MT3, MT2A), and tumorigenesis (SCGB2A2, S100A9, YWHAE, SFN, ATP6AP1, MGC5528, ASS, TACC3, ARHGAP4, SRA1; MGC35136, PSAP, SPTAN1, LGALS3BP, TUBA4, AMY2B, PPIA, COX1, GRB2, CTSL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_provenance.
- NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion evidence source_evidence_literature NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_provenance.
- NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion SIO_000772 16773180 NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_provenance.
- NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion wasDerivedFrom befree-2016 NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_provenance.
- NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_assertion wasGeneratedBy ECO_0000203 NP554502.RAeMhkGNYX3Ai8_KSx4w7oluIzU1p5VsOqnUpPxHrQ_7Y130_provenance.